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Taura syndrome virus (TSV), a pathogen of penaeid
shrimp and member of the family Dicistroviridae, was
recently reported to have the ability to infect primate cells.
We independently retested this hypothesis. Three lines of
primate cells FRhK-4, MA-104, and BGMK, which are high-
ly susceptible to infection by human picornaviruses, were
challenged with TSV. Viral replication was assayed by real-
time reverse transcription–polymerase chain reaction using
cell media samples collected on days 0, 4, and 7 postchal-
lenge. By day 7, genome copy numbers had decreased
25%–99%. No cytopathic effect was observed after 7 days.
An in situ hybridization assay, with gene probes specific for
detection of TSV, was negative for TSV in challenged cells.
The infectivity of residual virus in the cell culture media at
day 7 was confirmed by bioassay using TSV-free indicator
shrimp (Litopenaeus vannamei). TSV did not infect the pri-
mate cells tested, and no evidence of zoonotic potential
was found. 
T
he general assumption is that the viral agents that
cause disease in penaeid shrimp do not infect verte-
brates. Supporting this assumption is the absence of docu-
mented cases of any shrimp virus causing disease in any
animal species other than crustaceans. In a recent article,
Taura syndrome virus (TSV), exclusively a pathogen of
penaeid shrimp, was attributed a zoonotic potential
because of its reported ability to infect cultured human and
monkey cells (1). Aside from the food safety issues raised
by this report, we were very interested in confirming those
results because of the practical value of this new option for
growing TSV in vitro. To date, TSV (or any other of the
known viruses of the penaeid shrimp) has not yet been suc-
cessfully cultured in any invertebrate or vertebrate cell-
culture system. Hence, if viable, the use of primate cells
for propagation of TSV would prove to be an important
advancement in the study of TSV, and perhaps of other
crustacean viruses. While the experiment reported in this
study did not include all of the cell lines used by Audelo-
del-Valle et al. (1), namely human rhabdomyosarcoma
(RD), human larynx carcinoma (Hep-2), and Buffalo green
monkey kidney (BGMK), the three cell lines that we used
are also routinely used for virus isolation and diagnosis of
diseases caused by human enteroviruses that belong to the
family Picornaviridae (2–7). TSV, is a member of the fam-
ily  Dicistroviridae (closely related to Picornaviridae),
genus Cripavirus (8,9). Other than TSV, which only infects
penaeid shrimp, members of the genus Cripavirus are
known to infect only insects (9). We report the results
obtained after performing an experiment to test the hypoth-
esis proposed by Audelo-del-Valle et al. (1).
Materials and Methods
Source of TSV
Rather than using TSV-infected shrimp originated from
shrimp farms as a source, TSV infection was induced
under laboratory conditions by injecting specific pathogen
free (SPF) shrimp (10) Litopenaeus vannamei with puri-
fied TSV reference isolate Hawaii-94 (11). The use of SPF
shrimp ensured that no contamination with other viral
pathogens would interfere with the experiment.
Hemolymph and hepatopancreas were obtained from
moribund shrimp during the acute phase of Taura syn-
drome and used to prepare the viral inocula.
Preparation of Inocula
Hemolymph was drawn from a moribund shrimp with
acute-phase Taura syndrome and the hepatopancreas was
excised by using aseptic technique. The hemolymph was
diluted 1:10 with Eagle’s balanced salts minimum      essen-
tial medium (EMEM), without fetal bovine sera (FBS), and
filtered through a syringe filter of 0.22-µm pore size. The
hepatopancreas was homogenized in 10 mL of EMEM
without FBS, centrifuged at 125 x g for 2 min to eliminate
coarse material and the supernatant filtered with a syringe
filter of 0.22-µm pore size. Samples of hemolymph and
hepatopancreas from SPF shrimp were processed in identi-
cal manner and used as a negative control.
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The lines and cell cultures used were African green
monkey kidney (BGMK), Monkey Rhesus female kidney
embryonic (FRhK-4), and Monkey African green kidney
(MA-104). Other than the report by Audelo-del-Valle et al.
(1), TSV culture or CPE has not been reported in any
invertebrate or vertebrate cell line. Hence, no positive con-
trol for TSV-induced CPE in cell culture was included in
this study. 
TSV Injection
Each of four 75-cm2 flasks of confluent monolayers of
each cell line (BGMK, FRhK-4, and MA-104) was inject-
ed with 0.1 mLof either of the four inocula: 1) hemolymph
from shrimp with acute-phase Taura syndrome, 2)
hepatopancreas from shrimp with acute-phase Taura syn-
drome, 3) hemolymph from SPF shrimp, or 4) hepatopan-
creas from SPF shrimp. After injection, the standard
volume (15 mL) of fresh EMEM with 2% FBS was added
without removing the inoculum. The cells were incubated
at 37°C and monitored once a day for 7 days for cytopath-
ic effect (CPE). As an additional negative control, one
flask of each of the three cell lines was left untreated but
monitored once a day alongside the TSV-injected flasks. 
As an additional test to determine if a productive TSV
infection occurred, representative samples of cells at day 7
were collected with a sterile pipette and pelleted at
130 x g. The pellet of cells was fixed in Davidson’s AFA
(alcohol, formaldehyde, and acetic acid) fixative and
processed by using conventional techniques for paraffin
embedding and sectioning. Paraffin sections were subject-
ed to in situ hybridization with a mixture of two gene
probes, P15 and Q1, specific for detection of TSV (12),
according to protocols published elsewhere (13,14).
TSV Quantification 
RNA Extraction 
A total of 0.2 mL from each of the original inocula
(inocula prepared from the hemolymph and hepatopan-
creas of infected and noninfected shrimp) and 0.2 mL of
cell culture media from each of the three different cell line
cultures collected at days 0, 4, and 7 postexposure, were
subjected to RNA extractions using a High Pure RNA tis-
sue kit (Roche Molecular Biochemicals, Indianapolis, IN),
according to the manufacturer’s recommendations. The
concentration of extracted RNA was estimated by measur-
ing optical density, OD260nm, with an Eppendorf spec-
trophotometer.
Real-Time TSV RT-PCR
The real time TSV RT-PCR assays were performed
using an ABI GeneAmp 5700 with TaqMan One-Step RT-
PCR master mixture (Applied Biosystems, Foster City,
CA). The reaction mixture contained no more than 10 ng
of extracted RNA, with each primer at a concentration of
0.3 µmol/L, and the TaqMan probe at a concentration of
0.1 µmol/L in a final volume of 25 µL. The cycling con-
sisted of 30 min at 48°C for reverse transcription and 10
min at 95°C, followed by 40 cycles of 95°C for 15 s, and
60°C for 1 min. The data acquisition and analysis were car-
ried out with GeneAmp 5700 Sequence Detector Software
(Applied Biosystems). The real-time RT-PCR primers and
TaqMan probe for the detection of TSV had been previ-
ously designed from ORF1 region of the TSV genomic
sequence (15). Serial dilutions from a previously con-
structed TSV plasmid were used to determine a standard
linear relationship for quantification with a correlation of
the serial dilutions >0.99. 
Confirmation of TSV Infectivity
Bioassay
To confirm the infectivity of the virus, a 6-day bioassay
was performed by injecting groups of four to six SPF indi-
cator shrimp (L. vannamei) with approximately 200 µLo f
either of the following: 1) inoculum prepared from
hemolymph of infected shrimp; 2) inoculum prepared
from hemolymph of noninfected shrimp; 3) cell media col-
lected at day 7 from TSV-challenged cell culture flasks; or
4) culture media collected at day 7 from SPF shrimp tis-
sue–treated cell culture flasks (negative control). The
shrimp were monitored once a day for signs of disease.
Moribund shrimp were collected when observed, pre-
served in Davidson’s fixative and transferred into 70%
ethanol after 24 h (14,16). All surviving shrimp at termi-
nation of the bioassay (day 6) were preserved in the same
manner. Shrimp tissue samples were processed according
to conventional techniques for paraffin embedding and
sectioning (16). Paraffin sections were stained with Mayer-
Bennett’s hematoxylin/eosin-phloxin and subjected to his-
tologic evaluation to determine the presence of TSV
diagnostic lesions. Selected specimens were subjected to a
confirmatory assay by in situ hybridization (ISH) with a
mixture of two gene probes, P15 and Q1, specific for
detection of TSV (12–14).
Results
Cytopathic Effect (CPE)
No CPE was observed in any of the three cell lines
injected with TSV infected hemolymph, TSV infected
hepatopancreas, SPF shrimp hemolymph, or SPF shrimp
hepatopancreas (Figure 1). The BGMK cell line showed
normal fibroblastic structure throughout the 7-day period
of exposure to the different treatments. The BGMK
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detachment or lysis. Similarly, the FRhK-4 and the
MA-104 cell lines retained their typical epithelial structure
for the 7-day period after exposure to TSV, with confluent
monolayers and no evidence of cell detachment or lysis. 
Virus Quantification
Approximately 1.3 x 105 to 2.7 x 106 viral copies/µL
were detected at day 0 in the tissue cell flasks exposed to
TSV-infected hemolymph. In the case of the tissue cell
flasks exposed to TSV-infected hepatopancreas, ≈1.2 x 104
viral copies/µLwere detected (Table). TSV was not detect-
ed by real time RT-PCR in the inoculum prepared from
SPF shrimp hemolymph and hepatopancreas, nor in the tis-
sue cell culture flasks exposed to these inocula.
At day 7, real time RT-PCR showed a decrease of 25%
to 99% of the TSV genome copy number in the tissue cell
culture flasks exposed to TSV (Figure 2), which suggests
that no viral replication had occurred but that some resid-
ual virus remained from the inoculum. 
Bioassay
Samples of cell-culture media from tissue culture flasks
injected with TSV-infected hemolymph were collected at
day 7 and used to inject SPF indicator shrimp L. vannamei
to determine the infectivity of the residual virus. Moribund
shrimp from these bioassays were examined by conven-
tional hematoxylin/eosin-phloxin histology and by in situ
hybridization with the gene probes specific for detection of
TSV. TSV infection was diagnosed in all of the moribund
shrimp, which indicates that at 7 days after injection, the
tissue culture media contained sufficient residual TSV to
produce infections in challenged shrimp (Figure 3).
Paraffin sections from known TSV-infected and noninfect-
ed shrimp were used as ISH positive and negative controls,
respectively (results not shown). 
During this study, a relationship was observed between
the concentration of TSV in the inocula prepared from day
7 tissue culture media (from cells exposed to TSV-infected
hemolymph) and the severity of TSV infection in the chal-
lenged SPF indicator shrimp. The shrimp that had been
injected with tissue cell culture media with the highest
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Figure 1. Absence of cytopathic effect after a 7-day exposure of three lines of primate cells (FRhK-4, MA-104, and BGMK) to an inocu-
lum prepared with hemolymph from Taura syndrome virus (TSV)-infected shrimp (Litopenaeus vannamei) during the acute phase of the
disease compared to a control inoculum containing hemolymph from specific pathogen free (SPF) shrimp. A) FRhK-4 cells exposed to
SPF hemolymph; B) FRhK-4 cells exposed to TSV hemolymph; C) MA-104 cells exposed to SPF hemolymph; D) MA-104 cells exposed
to TSV hemolymph; E) BGMK cells exposed to SPF hemolymph; F) BGMK cells exposed to TSV hemolymph (no stain; 25x).TSV concentration (≈2.5 x 104 viral copies/µL) developed
an acute (overt) infection within 3 days postchallenge,
whereas shrimp injected with tissue cell culture media with
the lowest viral concentration (≈2.3 x 103 viral copies/µL)
developed only a subacute (covert) infection. Both overt
and covert infections were confirmed by histologic analy-
sis and by ISH with gene probes specific for detection of
TSV (Figure 4). 
Additional ISH Test 
As an additional test to further confirm the absence of
viral replication, the accumulation within the cells, or both,
a sample of cells at day 7 was obtained from the BGMK
cell line and subjected to ISH with TSV-specific gene
probes. The BGMK cell line was selected for this assay
because, among all three lines, it had the highest initial
(day 0) concentration of viral particles and a 2 log reduc-
tion at day 7, suggesting either degradation or internal-
ization of the virus. The ISH assay gave negative results
(Figure 5), which indicates degradation as the more likely
explanation for the reduction in virus content of the cell
media. As in previous ISH assays, paraffin sections from
known TSV-infected and noninfected shrimp were used as
ISH-positive and -negative controls, respectively (results
not shown). 
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Figure 2. Example of the decrease on
Taura syndrome virus (TSV) genome copy
number within tissue cell culture flasks
exposed to TSV. A) Real time reverse tran-
scription–polymerase chain reaction plots
and mean quantity of TSV copies/µL from
tissue cell culture media collected at days
0, 4, and 7 postinfection from MA-104 cell
flasks injected with TSV-infected shrimp
hemolymph. Samples of tissue cell culture
media collected from FrhK-4 and BGMK
cell culture flasks inoculated with TSV-
infected hemolymph or hepatopancreas
also decreased by >1 log in concentration
of viral copies as a function of time. The
value of 33.79 obtained for one of the no
template control (NTC) replicates is con-
sidered an artifact. B) Standard curve of
TSV copy number versus threshold cycle
(Ct) value. Purified TSV plasmid was seri-
ally diluted and used as templates in real-
time polymerase chain reaction. The
resulting Ct values are plotted against the
logarithm of their respective copy numbers
(C0). Rn, fluorescence signal; SPF 1 and 2,
specific pathogen free.Discussion
The real-time RT-PCR results (Table) show that the
number of TSV genome copies in the cell culture media
did not increase for any of the three cell lines challenged
with TSV. While differences were observed in the estimat-
ed number of viral copies in each flask at day 7, the num-
ber of viral copies present was from one to two logs less
than that of the day 0 values, which were determined
immediately after cells were injected. The apparent plateau
of TSV counts at day 7, regardless of the concentration of
viral particles in each flask at day 0, may have been due to
a protective effect of the cell-culture media, specifically
the fetal bovine serum (FBS). This protective effect of FBS
on viruses has been documented by other researchers
(17–20). Studies on viral transport media for the preserva-
tion of virus viability have concluded that the best trans-
port media for specimens at risk of being delayed by long
transit times and exposed to significant temperature varia-
tions en route, are those that contain 2% FBS (i.e., CVM-
Copan Diagnostics, Corana, CA, and M4-Multi-Microbe,
Micro Test, Inc., Snellville, GA). 
To further confirm the absence of viral replication or
accumulation within the cells, a sample of cells at day 7
was obtained from the BGMK cell line and subjected to
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Figure 3. Histologic section through the anterior gastric chamber of a moribund juvenile Litopenaeus vannamei that was injected with an
inoculum prepared with tissue cell culture media from BGMK cells exposed to Taura syndrome virus (TSV) (day 7 postexposure). A) The
arrows point to a portion of cuticular epithelium displaying diagnostic acute-phase TSV lesions (hematoxylin/eosin-phloxin stain; 50x). B)
The dashed arrows point to a portion of the stomach epithelium from the same shrimp, where digoxigenin (DIG)-labeled TSV-specific
gene probes were reacted by in situ hybridization (ISH), resulting in the deposition of a black precipitate on areas where the probe
hybridized with target TSV (Bismarck Brown counterstain; 50x).
Figure 4. Covert Taura syndrome virus (TSV) infection (transition/chronic phase of TS disease) in indicator specific pathogen free-
Litopenaeus vannamei shrimp was confirmed by in situ hybridization (ISH) with digoxigenin-labeled gene probes specific for detection of
TSV. A) Histologic section through the dorsal cuticular epithelium showing a melanized resolving lesion (MZ) and hemolytic congestion
(HCg), indicative of the transition phase of TSV infection (hematoxylin/eosin-phloxin stain; 50x) . B) TSV ISH on the consecutive section
to that shown in 5A, where binding of the TSV probes is shown by the black precipitate (arrow) indicating the presence of TSV within the
cytoplasm of cells of the cuticular epithelium (Bismarck Brown counterstain; 50x).ISH with TSV-specific gene probes. The absence of reac-
tion to the TSV probes and the absence of CPE indicate that
viral replication did not occur in the BGMK cells and that
if any viral particles were internalized, they were degraded. 
The relationship observed between the concentration of
TSV in the inocula prepared from day 7 tissue culture
media (from cells exposed to TSV-infected hemolymph)
and the severity of TSV infection in the challenged SPF
indicator shrimp agree with the results obtained during a
previous study in the authors’ laboratory, in which it was
concluded that a minimum concentration of ≈ 1.0 x 104
viral copies/µL is necessary to induce an acute infection
(21). In this case, those shrimp that had been injected with
tissue cell culture media with the highest TSV concentra-
tion (≈2.5 x 104 viral copies/µL) developed an acute
(overt) infection within 3 days postchallenge, whereas
shrimp injected with tissue cell culture media with the low-
est viral concentration (≈2.3 x 103 viral copies/µL) devel-
oped only a subacute (covert) infection.
BGMK, FRhK-4, and MA-104 cell lines are often used
for isolation and research purposes for enteroviral menin-
gitis (3), hepatitis A virus (7), polioviruses, coxsackie A,
and coxsackie B (22) because of their marked susceptibil-
ity to infection by these members of the Picornaviridae.
When exposed to any of these agents, these cell lines
develop conspicuous CPE within ≈5 days (3,7,22,23).
However, no CPE in any of the three cell lines (BGMK,
FRhK-4, and MA-104) challenged with TSV was observed
in this experiment, even at day 7 postinjection. These
results contradict those of Audelo-del-Valle et al. (1), who
reported the development of CPE within 19–23 hours. The
average incubation time required for CPE development
(induced by enteroviruses) in human or monkey cells at
37°C is 5 days, although detection time may be reduced to
≈3 days by use of the shell vial method (23). Shorter incu-
bation times of <24 hours for CPE development could be
more suggestive of a toxicity problem rather than of virus
induced CPE.
As mentioned above, SPF shrimp (L. vannamei) were
used to amplify a reference strain of TSV to prepare the
inocula. We used SPF shrimp for three reasons. First,
pond-reared or wild shrimp may harbor human or other
mammalian picornaviruses. Shrimp and other decapod
crustaceans have been shown to internalize and passively
carry certain fish viruses (24–26) and human enterovirus-
es (27, C. Gerba, unpub. data). Hence, wild or pond-reared
shrimp may be passive carriers of human or other mam-
malian pricornaviruses or other viruses which could pro-
duce CPE in studies such as that reported by
Audelo-del-Valle et al. (1). Second, by using a commer-
cially available line of SPF shrimp, the experiment can be
standardized; therefore, other researchers can repeat or
confirm the present study. Third, the SPF shrimp used are
produced in closed biosecure systems with controlled
water sources, which preclude chance contamination of the
stocks with human or other animal viruses.
BGMK cells were the only cell type in common
between our study and that of Audelo-del-Valle et al (1),
who also used RD and Hep-2 however, BGMK, FRhK-4,
and MA-104 cells were selected for use in our study
because these cell types have a marked susceptibility to
infection by members of Picornaviridae (28), which
makes them as adequate as RD or Hep-2 cells for deter-
mining the possible infectivity of TSV to primate cells. We
conclude that TSV did not infect the primate cells chal-
lenged with TSV in our study. 
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Figure 5. Absence of reaction by in situ hybridization (ISH) to the digoxigenin (DIG)-labeled Taura syndrome virus (TSV) probes within
the BGMK cells harvested at day 7 postinjection with TSV. A) No cytopathic effect suggestive of TSV infection was evident by conven-
tional hematoxylin/eosin-phloxin (H&E) histology (H&E stain; 100x). B) Consecutive histologic section to that shown in Figure 4A, but
subjected to ISH with DIG-labeled TSV probes specific for TSV. No reaction to TSV is apparent in the challenged cells (Bismarck Brown
counterstain; 100x). The lack of CPE in any of the three different cell lines
tested, the negative ISH results with TSV specific gene
probes assay of TSV challenged BGMK cells, and multi-
log reduction in TSV number in the cell-culture media as
determined by real time RT-PCR indicate that TSV did not
replicate in the primate cell lines used in our study. That
TSV infection had occurred in SPF indicator shrimp after
injection with media collected from day 7 cell culture
flasks indicates that sufficient residual TSV remained in
the media to infect the challenged shrimp and to cause
acute disease or subacute disease as a function of relative
concentration of residual TSV present.
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